{"id":13538,"date":"2020-05-05T20:13:11","date_gmt":"2020-05-06T00:13:11","guid":{"rendered":"http:\/\/www.embamcgillhec.ca\/en\/?p=13538"},"modified":"2022-12-07T14:58:38","modified_gmt":"2022-12-07T19:58:38","slug":"amelie-faubert-is-the-new-senior-director-corporate-development-at-nexelis","status":"publish","type":"post","link":"https:\/\/www.embamcgillhec.ca\/en\/2020\/05\/05\/amelie-faubert-is-the-new-senior-director-corporate-development-at-nexelis\/","title":{"rendered":"Am\u00e9lie Faubert (EMBA 2021*) is the new Senior Director, Corporate Development at Nexelis"},"content":{"rendered":"
<\/p>\n
Am\u00e9lie Faubert, a current McGill-HEC Montr\u00e9al EMBA<\/a> participant, recently joined Nexelis<\/a> as Senior Director, Corporate Development.<\/p>\n Nexelis is an immunology-centric contractual research organization specialized in preclinical models and clinical assay development in single and multiplex formats and sample analysis for low-, mid- and large-scale clinical testing. Nexelis contributes to saving lives by supporting pharmaceutical and biotech companies in the development of vaccines and large molecules.<\/p>\n With a master’s degree in immunology from University of Montreal and a PhD in experimental medicine from McGill University, and her experience working for two pharmaceutical leaders, Servier and Merck, Am\u00e9lie will undoubtedly be an asset for Nexelis.<\/p>\n “I firmly believe that the EMBA helped me to obtain this position and that all that I\u2019ve learned over the past months will enable me to have a very significant impact, very quickly, in this growing organization.”<\/p>\n<\/blockquote>\n<\/div>\n